Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Olga Arch"'
Autor:
Javier Cobo, Esperanza Merino, Cristina Martínez, Alberto Cózar-Llistó, Evelyn Shaw, Teresa Marrodán, Esther Calbo, Elena Bereciartúa, Luis A. Sánchez-Muñoz, Miguel Salavert, M. Teresa Pérez-Rodríguez, Dácil García-Rosado, J. María Bravo-Ferrer, Juan Gálvez-Acebal, César Henríquez-Camacho, Jordi Cuquet, Berta Pino-Calm, Luis Torres, Antonio Sánchez-Porto, Borja M. Fernández-Félix, José Romero, Alfonso Muriel, Livia Giner, Vicente Boix, Antonio Ramos-Martínez, Rocío Martínez, Purificación Martos, Olga Arch, Cristina Sardiña, Elena Aguirre, Cristina Badía, Lucía Boix, Ildefonso Perales, Pedro A. De Santos-Castro, Miguel Angel Bratos-Pérez, Sandra Cuellar, Eva González, Adriana Soto, Adrián Sousa, Pedro Llinares, Laura Castelo, Isabel Morales, Jesús Sojo, Alberto Delgado-Iribarren, Carmina Martí, Rosa Vázquez, Pilar Mairal
Publikováno v:
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Recurrence of Clostridium difficile infection (CDI) has major consequences for both patients and the health system. The ability to predict which patients are at increased risk of recurrent CDI makes it possible to select candidates for treatment with
Autor:
Rosa M. Granada, Jordi Càmara, Laura Gavaldà, Olga Arch, Montserrat Ferrer, M. Angeles Domínguez, Rosa Gasull, Evelyn Shaw, Miquel Pujol, Ana Soriano
Publikováno v:
American journal of infection control. 44(5)
Background Our institution experienced an endemic situation with extensively drug-resistant (XDR) Acinetobacter baumannii in the intensive care units (ICUs). Here, we describe the long-term results of the implementation of a screening and cohorting p
Autor:
Timofey Komarov, Polina Karnakova, Olga Archakova, Dana Shchelgacheva, Natalia Bagaeva, Mariia Popova, Polina Karpova, Kira Zaslavskaya, Petr Bely, Igor Shohin
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2356 (2023)
Molnupiravir is an antiviral drug against viral RNA polymerase activity approved by the FDA for the treatment of COVID-19, which is metabolized to β-D-N4-hydroxycytidine (NHC) in human blood plasma. A novel method was developed and validated for qua
Externí odkaz:
https://doaj.org/article/78eeaa2324f44d79849478681727fc26
Autor:
Carmen Peña, Fe Tubau, Olga Arch, Miquel Pujol, Cristina Suárez, Antonio Oliver, Silvia Gómez-Zorrilla, Javier Ariza, María Ángeles Domínguez
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 31(10)
Several studies have suggested that resistance determinants usually reduce virulence. However, their contribution to decrease bloodstream infections is unclear. Our aim was to identify risk factors of extensively drug-resistant (XDR) Pseudomonas aeru
Autor:
Javier Ariza, Carmen Peña, Laura Gavaldà, Cristina Suárez, Fe Tubau, Mercedes Sora, Antonio Oliver, M. Angeles Domínguez, Olga Arch, Carlos Juan, Miquel Pujol
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Infectious Diseases, Vol 11, Iss 1, p 272 (2011)
BMC Infectious Diseases
instname
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Infectious Diseases, Vol 11, Iss 1, p 272 (2011)
BMC Infectious Diseases
Background: Studies of recent hospital outbreaks caused by multiresistant P. aeruginosa (MRPA) have often failed to identify a specific environmental reservoir. We describe an outbreak due to a single clone of multiresistant (MR) Pseudomonas aerugino